sucrose has been researched along with ferlixit in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 11 (64.71) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faich, G; Strobos, J | 1 |
| Lindsay, RM; Nissenson, AR; Seligman, P; Strobos, J; Swan, S | 1 |
| Bahner, U; Bettger, H; Kosch, M; Matzkies, F; Schaefer, RM; Teschner, M | 1 |
| Duffy, CI | 1 |
| Agarwal, R; Panesar, A | 1 |
| Adkinson, NF; Agarwal, R; Batlle, D; Coyne, DW; Dahl, N; Eschbach, JW; Fishbane, S; Folkert, V; Michael, B; Myirski, P; Nissenson, AR; Strobos, J; Trout, JR; Warnock, DG | 1 |
| Albarracín, C; Fanlo, B; Junquera, E; Rodríguez Palomares, JR | 1 |
| Kosch, M; Schaefer, RM | 1 |
| Ferrara, I; Hörl, WH; Kletzmayr, J; Perschl, A; Sengoelge, G; Sunder-Plassmann, G | 1 |
| Anderson, J; Johnson, K; Van Wyck, D | 1 |
| Bailie, GR; Clark, JA; Lane, CE; Lane, PL | 1 |
| Ahlmén, J; Chertow, GM; Mason, PD; Vaage-Nilsen, O | 1 |
| Orfitelli, C; Robbins, KC | 1 |
| Yee, J | 1 |
| Gupta, A; Olp, J; Pai, A; Reddy, S; Zha, J; Zhuo, J | 1 |
| Baribeault, D | 2 |
2 review(s) available for sucrose and ferlixit
| Article | Year |
|---|---|
Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
Topics: Anaphylaxis; Anemia, Iron-Deficiency; Drug Carriers; Drug Hypersensitivity; Drug Utilization; Europe; Ferric Compounds; Germany; Hematinics; Humans; Iron-Dextran Complex; Italy; Renal Dialysis; Sucrose; United States | 1999 |
[Indications and practical management of parenteral iron therapy].
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Child; Erythrocyte Count; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Male; Renal Dialysis; Sucrose; Time Factors; Transferrin | 2003 |
4 trial(s) available for sucrose and ferlixit
| Article | Year |
|---|---|
Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
Topics: Adult; Aged; Analysis of Variance; Anemia, Iron-Deficiency; Drug Administration Schedule; Drug Carriers; Female; Ferric Compounds; Ferritins; Hematinics; Hematocrit; Hemoglobins; Humans; Infusions, Intravenous; Male; Middle Aged; Patient Selection; Renal Dialysis; Sucrose; Transferrin; Treatment Outcome; United States | 1999 |
A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
Topics: Drug Administration Schedule; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Recombinant Proteins; Renal Dialysis; Sucrose; Time Factors; Transferrin | 2001 |
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
Topics: Drug Hypersensitivity; Female; Ferric Compounds; Humans; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Mast Cells; Middle Aged; Prospective Studies; Renal Dialysis; Serine Endopeptidases; Sucrose; Tryptases | 2003 |
Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
Topics: Adult; Anemia, Iron-Deficiency; Drugs, Generic; Erythropoietin; Female; Ferric Compounds; Humans; Infusions, Intravenous; Male; Recombinant Proteins; Renal Dialysis; Sucrose; Sweetening Agents; Time Factors | 2011 |
11 other study(ies) available for sucrose and ferlixit
| Article | Year |
|---|---|
Iron sucrose or ferric gluconate?
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Renal Dialysis; Sucrose; Terminology as Topic | 2001 |
Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease.
Topics: Administration, Oral; Aged; Anemia, Iron-Deficiency; Clinical Pharmacy Information Systems; Databases as Topic; Drug Administration Schedule; Erythropoietin; Female; Ferric Compounds; Glomerular Filtration Rate; Humans; Hypotension; Iron; Kidney Failure, Chronic; Male; Medical Records; Recombinant Proteins; Retrospective Studies; Sucrose; Treatment Outcome; Veterans | 2002 |
[Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
Topics: Aged; Aged, 80 and over; Anemia; Cost-Benefit Analysis; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spain; Sucrose | 2003 |
Impairment of transendothelial leukocyte migration by iron complexes.
Topics: Cell Movement; Cells, Cultured; Endothelium, Vascular; Ferric Compounds; Gluconates; Humans; Multivariate Analysis; Neutrophils; Sucrose; Umbilical Veins | 2003 |
Labile iron in parenteral iron formulations: a quantitative and comparative study.
Topics: Biological Assay; Chemistry, Pharmaceutical; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron-Dextran Complex; Protein Binding; Sucrose; Transferrin | 2004 |
Hypersensitivity reactions and deaths associated with intravenous iron preparations.
Topics: Adverse Drug Reaction Reporting Systems; Algorithms; Anaphylaxis; Drug Hypersensitivity; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Retrospective Studies; Severity of Illness Index; Sucrose; United States | 2005 |
Update on adverse drug events associated with parenteral iron.
Topics: Adverse Drug Reaction Reporting Systems; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Sucrose | 2006 |
Successful use of sodium ferric gluconate in sucrose in a patient with multiple drug allergies.
Topics: Adult; Anemia, Iron-Deficiency; Drug Combinations; Drug Hypersensitivity; Ferric Compounds; Ferritins; Hematocrit; Hemoglobins; Humans; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Patient Care Planning; Renal Dialysis; Sucrose; Treatment Outcome | 2000 |
Iron replacement therapy: assessing today's options to prepare for bundling.
Topics: Anemia, Iron-Deficiency; Chemistry, Pharmaceutical; Dextrans; Drug Costs; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Medicare; Reimbursement Mechanisms; Renal Dialysis; Risk Adjustment; Safety; Sucrose; Treatment Outcome; United States | 2010 |
Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival.
Topics: CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; GPI-Linked Proteins; Humans; Iron-Dextran Complex; Lymphocyte Subsets; Molecular Weight; Oxidative Stress; Reactive Oxygen Species; Receptors, IgG; Sucrose | 2010 |
Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Child; Drug Stability; Drugs, Generic; Female; Ferric Compounds; Hematinics; Humans; Male; Middle Aged; Sucrose; Sweetening Agents | 2011 |